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Oxidative stressThe study has demonstrated that dopamine induces membrane depolarization and a loss of phosphorylation
capacity in dose-dependent manner in isolated rat brain mitochondria during extended in vitro incubation
and the phenomena are not prevented by oxyradical scavengers or metal chelators. Dopamine effects on brain
mitochondria are, however, markedly prevented by reduced glutathione and N-acetyl cysteine and promoted
by tyrosinase present in the incubation medium. The results imply that quinone oxidation products of
dopamine are involved in mitochondrial damage under this condition. When PC12 cells are exposed to
dopamine in varying concentrations (100–400 μM) for up to 24 h, a pronounced impairment of mitochondrial
bio-energetic functions at several levels is observed along with a signiﬁcant (nearly 40%) loss of cell viability
with features of apoptotic nuclear changes and increased activities of caspase 3 and caspase 9 and all these
effects of dopamine are remarkably prevented by N-acetyl cysteine. N-acetyl cysteine also blocks nearly
completely the dopamine induced increase in reactive oxygen species production and the formation of
quinoprotein adducts in mitochondrial fraction within PC12 cells and also the accumulation of quinone
products in the culture medium. Clorgyline, an inhibitor of MAO-A, markedly decreases the formation of
reactive oxygen species in PC12 cells upon dopamine exposure but has only mild protective actions against
quinoprotein adduct formation, mitochondrial dysfunctions, cell death and caspase activation induced by
dopamine. The results have indicated that quinone oxidation products and not reactive oxygen species are
primarily involved in cytotoxic effects of dopamine and the mitochondrial impairment plays a central role in
the latter process. The data have clear implications in the pathogenesis of Parkinson's disease.9874489805.
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The dopaminergic neuronal death in Parkinson's disease (PD) may
involve a complex interplay of genetic and extra-genetic mechanisms
but mitochondrial dysfunction and oxidative stress are thought to be
crucial in this process as indicated from studies in experimental
models and analysis of post mortem brain samples of PD patients
[1–4]. Experimental models of PD have utilized both animals and
cultured cells exposed to various toxins like MPTP (N-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine), 6-hydroxy dopamine or rotenone
to induce neuronal death in which oxidative stress, mitochondrial
impairment and apoptosis have been implicated [5–9]. Although these
models are useful, MPTP, rotenone and 6-hydroxy dopamine are
not endogenously available and as such it is not clear whether the
proposed mechanisms of actions of these toxins really represent
the in vivo scenario in sporadic PD. On the other hand endogenouslyavailable dopamine (DA) in nigral neurons can undergo autoxidation
or enzyme catalyzed oxidation to produce reactive oxygen species
(ROS) and an array of toxic quinones and both these groups of
compounds have been implicated in the pathogenesis of PD [10–12].
The toxic effects of DA which have been extensively studied on
cultured cells of neural origin or on isolated brain mitochondria or in
animal models are, therefore, of physiological signiﬁcance and such
systems serve as useful tools to understand PD pathogenesis [13–19].
Dopamine induced apoptosis has been consistently shown in some of
these models and post-mortem studies have also demonstrated the
features of apoptosis in PD brains and thus these models have been
validated to an extent in explaining PD pathogenesis or searching for
new therapeutic targets [20–23]. However,manyuncertainties exist as
to the mediators and mechanisms of DA induced cell death in such
models. Apart from mitochondrial impairment, the inactivation of
proteasomal activity or the activation of nuclear factor-κB (NF-κB) or
various mitogen-activated protein kinase (MAPK) pathways like p38
family of kinases or c-Jun N-terminal kinases (JNK) has also been
implicated inDA-induced cytotoxicity and likewise the involvement of
autophagic and necrotic death instead of apoptosis has been suggested
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quinones in DA mediated cytotoxicity also remain unresolved,
although this information may be critical in developing or screening
neuroprotective drugs for PD using such model systems.
Although many studies have demonstrated the importance of ROS
in DA cytotoxicity in experimental models, the antioxidants like
vitamin C and vitamin E and the enzymes like SOD and catalase have
variable protective effects in such systems and the use of antioxidants
have met with near complete failure as neuroprotective agents in
PD in clinical trials [22,26,32]. On the other hand the role of toxic
quinones in DA induced neuronal damage has been studied in a
relatively few studies, although these reactive nucleophiles have been
shown to damage various brain sub-cellular components including
mitochondria and inactivate different enzymes during in vitro
incubation [12,19,33–36]. The present study has been undertaken to
critically review the damaging effects of DA on isolated mitochondria
with regard to the involvement of ROS and toxic quinones as an
extension of our earlier published work and further to examine if
similar mechanisms are also operative when intact rat pheochromo-
cytoma (PC12) cells are exposed to DA. In addition the consequences
of DA effects on mitochondrial bioenergetics in the context of cell
death and apoptosis have been worked out and agents that can block
these processes have also been tested. The results of this study are
therefore relevant not only in understanding the etiopathogenesis
of PD but also in ﬁnding suitable neuroprotective agents against this
disease condition.
2. Materials and methods
2.1. Animals
Young albino rats of ‘Charles–Foster’ strain (5–6 months old, body
weight 120–150 g) kept on commercially available laboratory chow
and water ad libitum were used in this study. The animals were
maintained and used as per the regulations and guidelines of the
‘Animal Ethical Committee’ of the Institute.
2.2. Isolation of rat brain mitochondria and incubation with DA
Rat brain mitochondria were isolated by a method based on
differential centrifugation with digitonin treatment as published
earlier [16,19]. The ﬁnal mitochondrial pellet was suspended in
isotonic buffer A (145 mM KCl, 50 mM sucrose, 1 mM EGTA (ethylene
glycol tetraacetic acid), 1 mMMgCl2, 10 mMphosphate buffer, pH 7.4)
and incubated immediately with or without DA (100–400 μM) in the
presence or absence of catalase (50 μg/ml) or mannitol (20 mM) or
dimethyl sulfoxide (DMSO, 20 mM) or sodium benzoate (20 mM) or
diethylene triamine pentaacetate (DTPA, 0.1 mM) or N-acetylcysteine
(NAC, 2.5 mM) or reduced glutathione (GSH, 2.5 mM) for up to 2 h
in a total volume of 400 μl. At the end of the incubation the mito-
chondria were pelleted out and washed with an excess of isotonic
buffer A and ﬁnally resuspended in the same buffer. An aliquot of
resuspended mitochondria was then used immediately for the
measurement of transmembrane potential or phosphate utilization.
For some experiments, a short-term incubation of mitochondria with
DAwith or without tyrosinase (250 units/ml, Sigma Aldrich, USA) and
other additions was carried out.
2.3. Measurement of transmembrane potential of rat brain mitochondria
after DA exposure
The transmembrane potential in isolated mitochondrial suspension
was measured using the mitochondrial membrane potential sen-
sitive carbocyanine dye JC-1 (5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-
benzamidazolocarbocyanine iodide, Alexis Biochemicals, USA) as
described previously [37]. This lipophilic and cationic dye accumulateswithin mitochondria driven by the negative transmembrane potential
and forms concentration dependent J-aggregates. When excited at
490 nm, the monomeric form of the dye emits at 527 nm while the
J-aggregates show maximum emission at 590 nm [37,38]. Brieﬂy,
an aliquot of mitochondria (control or DA-treated or DA-treated in
the presence of other additions) was incubated at 37 °C for 30 min in
isotonic buffer A containing 10 mM pyruvate, 10 mM succinate and
1 mMADP in the presence of 5 μMJC-1. At the end of the incubation, the
dye loaded mitochondria were collected by centrifugation, washed
extensivelywith isotonic buffer A to remove the excess dye fromoutside
and then resuspended in the same buffer in appropriate dilution,
followed by themeasurement of strong redﬂuorescence of J-aggregates
(λex 490 nm, λem 590 nm) in a spectroﬂuorometer (FP 6300, JASCO
International Co., Japan).
2.4. Measurement of phosphorylation capacity of rat brain mitochondria
after DA treatment
The mitochondrial phosphate utilization was assayed following the
method published earlier [39,40]. Brieﬂy, in a total volume of 500 μl in a
medium containing 125 mM KCl, 75 mM sucrose, 0.1 mM EGTA, 1 mM
MgCl2, 10 mMHEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid), 2 mMphosphate, 0.3% BSA (bovine serumalbumin), 0.5 mMADP,
5 mM pyruvate, 10 mM succinate and 10 mM glucose was added
an aliquot of 50 μl mitochondrial suspension (control or DA-treated or
DA-treated in the presence of other additions) containing 100–150 μg of
protein, followed by the immediate addition of 5 units of hexokinase
(Sigma Aldrich, USA) and the incubation was continued at 37 °C for
30 min. The incubation was terminated by the addition of 5% ice cold
TCA (trichloroacetic acid) and the amount of inorganic phosphate
estimated spectrophotometrically using a reaction based on the
reduction of phosphomolybdate as described earlier [34]. A ‘0’-min
sample was also assayed for inorganic phosphate content where
hexokinase addition was immediately followed by the treatment with
5% ice-cold TCA. The difference in inorganic phosphate content between
0 and 30 min samples was calculated to estimate the phosphorylation
capacity of brainmitochondria. Glucose andADP in the reactionmixture
were used as a trap for ATP to maintain the level of ADP in the system
as also to prevent the release of free inorganic phosphate from ATP by
the action of various phosphatases.
2.5. PC12 cell culture and treatment paradigm
Rat pheochromocytoma (PC12) cells (National Centre for Cell
Sciences, Pune, India) were grown in RPMI 1640 medium (Gibco,
Invitrogen, USA) containing 10% heat-inactivated horse serum, 5% fetal
bovine serum, 2 mM glutamine, 50 units/ml penicillin, 50 μg/ml
streptomycin and 2.5 μg/ml amphotericin B (Gibco, Invitrogen, USA)
in a humidiﬁed environment containing 5% CO2 and 95% air at 37 °C.
Cells weremaintained and grown in 25-cm2 sterile tissue-culture ﬂasks
or 12-well plates and the experiments were conducted with varying
concentrations of DA(100–400 μM) for up to 24 hwith orwithout other
additions like NAC (2.5 mM), MAO-A inhibitor clorgyline (10 μM) or
TEMPOL (4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy, 1 mM) in the
culture medium. N-acetyl cysteine or clorgyline or TEMPOL was added
1 h prior to DA addition. For some experiments involving ﬂuorescence
microscopy, cells were harvested on poly-L-lysine (5 mg/ml) coated
glass coverslips.
2.6. Preparation of mitochondria from cultured PC12 cells
Mitochondria were isolated from cultured PC12 cells following the
method of Cui et al. with some modiﬁcations [41]. Control or treated
cells were thoroughly washed in phosphate buffered saline (PBS)
containing 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM
KH2PO4 and the cell pellet was resuspended in ice-cold cell-lysis
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(phenylmethylsulfonyl ﬂuoride)), kept on ice for 10 min and then
homogenized thoroughly followed by immediate addition of 1/3rd
volume of mitochondria stabilization buffer (1 M sucrose, 35 mM
EDTA, 50 mM Tris). The homogenate was then centrifuged at 2000×g
for 5 min at 4 °C and the supernatant collected and centrifuged at
12,000×g for 10 min at 4 °C to obtain the mitochondrial pellet.
Mitochondrial pellet was washed once in isotonic buffer B (145 mM
KCl, 50 mM sucrose, 5 mM NaCl, 1 mM EGTA, 1 mM MgCl2, 10 mM
phosphate, pH 7.4) and ﬁnally resuspended in either 50 mMphosphate
buffer, pH 7.4 or in 100 mM phosphate buffer, pH 7.4 for further
experimentation.
2.7. Measurement of ROS production in PC12 cells after DA exposure
Intracellular generation of ROS in PC12 cells was measured
by using ROS sensitive cell permeable ﬂuorescent dye 2′,7′-
diclorodihydroﬂuorescein diacetate (H2DCF-DA, Alexis Biochemicals,
USA). The dye was converted intracellularly to DCFH2 which in the
presence of ROSwasoxidized toDCF (2′,7′-dichloroﬂuorescein) a highly
ﬂuorescent compoundwithλex 475 nmandλem525 nm[42]. Cellswere
incubated with varying concentrations of DA (100–400 μM) with or
without other additions for 12–24 h. After the incubation the cells were
thoroughly washed in pre-warmed PBS and loaded with H2DCF-DA
(10 μM) for 30 min at 37 °C in the dark in Krebs–Ringer's buffer
(130 mM NaCl, 5 mM KCl, 10 mM glucose, 2 mM MgCl2, 1 mM CaCl2,
20 mM HEPES). The dye loaded cells were washed twice with Krebs–
Ringer's buffer and used for the measurement of DCF-ﬂuorescence.
The production of H2O2 following DA exposure was also mon-
itored by H2O2 speciﬁc ﬂuorescent dye Amplex Red (N-acetyl-3,7-
dihydroxyphenoxazine), a ﬂuorogenic substrate with very low back-
ground ﬂuorescence, that reacts with H2O2 with a 1:1 stoichiometry to
produce highly ﬂuorescent resoruﬁn [43]. In our study, the control
and experimental cells were thoroughly washed in PBS and incubated
with 50 μM amplex red reagent and 1 U/ml horseradish peroxidase in
pre-warmed Krebs–Ringer's buffer for 30 min in the dark at room
temperature. After the incubation with amplex red, cells were pelleted
down by centrifugation, and the ﬂuorescence intensity of the superna-
tant was measured in a JASCO FP-6300 spectroﬂuorometer at an
excitation wavelength of 560 nm and an emission wavelength of
590 nm with appropriate subtraction of the background ﬂuorescence.
2.8. Measurement of mitochondrial quinoprotein adduct formation in
PC12 cells
Quinoprotein formation was measured by the NBT (nitroblue
tetrazolium)/glycinate assay in the TCA-precipitated and delipidated
mitochondrial protein from PC12 cells following an earlier published
method [19,44]. The blue–purple colour developed in the reaction
mixture was suitably diluted and measured spectrophotometrically
at 520 nm.
2.9. Measurement of quinones and melanin by dopamine in cultured
PC12 cells
Quinone formation was monitored in the culture media following
exposure of PC12 cells to DA for 24 h by absorbance change at 480 nm
keeping the appropriate blank [19,45]. Melanin, the end product of
the autoxidation of dopamine, was also monitored spectrophotomet-
rically at 405 nm in the same cultured media [45].
2.10. Assessment of mitochondrial electron transport chain (ETC)
function in PC12 cells after DA exposure
NADH-ferricyanide reductase (Complex I) assay was carried out in
a reaction mixture (1 ml) containing 0.17 mM NADH, 0.6 mM ferricy-anide and 0.1% (v/v) triton X-100 in 50 mM phosphate buffer, pH 7.4.
The reaction was initiated by the addition of mitochondrial suspension
(10–30 μg) in the sample cuvette and the decrease in absorbance at
340 nm noted as described earlier [19,46]. The enzyme activity was
expressed as n moles of NADH oxidized/min/mg protein.
The activity of complex II–III (succinate–cytochrome c reductase)
was assayed by following the succinate supported reduction of
ferricytochrome c to ferrocytochrome c at 550 nm [46]. The sample
cuvette contained 100 mM phosphate buffer, 2 mM succinate, 1 mM
KCN, 0.3 mM EDTA and 1.2 mg/ml cytochrome c in a total volume of
1 ml. The reference cuvette contained all the reagents in the same
concentration except cytochrome c. The reaction was initiated by
adding mitochondrial suspension (10–30 μg) in the sample cuvette.
The increase in absorbance at 550 nm was monitored for a period of
3 min. The same assay was repeated with antimycin A (10 μM) to
determine the inhibitor sensitive rate. The enzyme activity was then
calculated by subtracting the antimycin A sensitive rate from overall
rate and expressed as μmoles oxidized cytochrome c reduced/min/mg
protein [46].
The activity of complex IV (cytochrome c oxidase) was assayed by
following the oxidation of reduced cytochrome c (ferrocytochrome c)
at 550 nm [19,46]. Reduced cytochrome (50 μM) in 10 mM phosphate
buffer, pH 7.4 was added in each of two 1 ml cuvettes. In the blank
cuvette ferricyanide (1 mM) was added to oxidize ferrocytochrome
c and the reaction is initiated in the sample cuvette by addition of
mitochondrial protein (10–30 μg). The rate of increase of absorbance
at 550 nm was measured at room temperatures. The activity was
calculated from ﬁrst order rate constant taking into account the
concentration of reduced cytochrome c in the cuvette and the amount
of mitochondrial protein added [19,46].
2.11. Measurement of mitochondrial transmembrane potential in
cultured PC12 cells after DA exposure
Mitochondrial transmembrane potential in intact PC12 cells was
measured by using JC-1 [38]. The monomeric form of the dye remains
distributed in the cytosol, whereas the dye accumulates within
mitochondria depending on the negative mitochondrial membrane
potential to form J-aggregates. When excited at 490 nm, the
monomeric dye emits at 527 nm whereas the J-aggregates emit at
590 nm. The ratio of ﬂuorescence intensities at 590 and 535 nm
measured within intact cells is considered indicative of mitochondrial
membrane potential [47]. For experimental purpose, control or
treated cells were washed twice with pre-warmed PBS, re-suspended
with 1 ml of serum free media containing JC-1 (ﬁnal concentration,
10 μM) and incubated for 30 min at 37 °C in the dark. The dye-loaded
cells were washed twice with pre-warmed serum free media to
remove the excess dye and then suspended in the same media in
appropriate dilution, followed by the measurement of ﬂuorescence
intensities (λex 490 nm, λem 535 and 590 nm) in a JASCO, FP 6300
spectroﬂuorometer.
2.12. Measurement of intracellular ATP concentration in cultured PC12
cells
The intracellular ATP content was measured in control and DA
treated PC12 cells by using a commercial kit based on luciferin–
luciferase reaction for ATP measurement (Sigma Aldrich, USA).
Brieﬂy, following incubation with DA for up to 24 h, the treated and
untreated control cells were washed with PBS to remove culture
media and aliquots (100 μl) of resuspended cells were disrupted by an
ice-cold lysis-buffer containing 10 mM Tris, 1 mM EDTA, 0.5% Triton
X-100, pH 7.6 and then immediately used for ATP measurement
using the ATP-assay mix provided by the kit [40]. The luminescence
generated thereafter was measured immediately in a microplate
luminometer (Biotek, ELX-800, USA). Appropriate blank reactions
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measure background luminescence. The intracellular content of ATP
was calculated from an ATP-standard curve generated by plotting the
luminescence readings against known concentrations of ATP solutions
provided in the kit and the values were expressed as nmol of ATP/mg
of protein [40].
2.13. Cell viability assay by trypan blue
An equal volume of trypan blue solution (0.4% in PBS) was added
to the cell suspension for 5 min and the number of stained and
unstained cells was counted. Typically, 250–300 cells were counted
in each group with a Neubauer counting chamber by an observer
blind to experimental history [47]. The cell death was expressed as
the percentage of trypan blue positive cells in the total population of
both stained and unstained cells.
2.14. Assessment of nuclear morphology of PC12 cells by Hoechst 33258
staining
For morphological assessment of apoptosis, a nuclear-chromatin
binding cell permeable dye Hoechst 33258 (2 ́́-(4-hydroxyphenyl)-5-
(4-methyl-1-piperazinyl)-2-5 ́-bi-1H-benzimidazole trihydrochloride
pentahydrate, Sigma Aldrich, USA) was used [48]. In brief, PC12 cells
were grown in the absence or presence of DA (400 μM) for 24 h on
poly-L-lysine coated glass coverslips. The cells were washed twice
with PBS, ﬁxed in 4% paraformaldehyde in PBS for 30 min and then
exposed to 1 μg/ml Hoechst 33258 dye for 30 min at 37 °C. The cells
were then rinsed twice with PBS, mounted on thin microscope slides
with mounting media containing 50% glycerol and 50% PBS and
visualized under a ﬂuorescence microscope (Carl Zeiss, Germany).
2.15. Measurement of caspase 3 and caspase 9 activity in PC12 cells
The caspase 3 activity in control and DA treated PC12 cells was
measured using a commercial kit (Promega, USA) which utilized a
luminogenic caspase-3 substrate (DEVD-aminoluciferin) and luciferase.
The cells were washed with PBS and aliquots (100 μl) of resuspended
cells were taken in 96 well plates. An equal volume of freshly prepared
caspase 3 reagent containing caspase 3 assay buffer and luminogenic
caspase 3 substrate was added to each well, mixed brieﬂy by orbital
shaking and incubated at 37 °C for 45 min in the dark. The luminescenceFig. 1. Loss of rat brain mitochondrial membrane potential after DA exposure. Rat brain mit
(100–400 μM) or (B) with DA (400 μM) in the presence or absence of GSH (2.5 mM) or NAC
(CAT, 50 μg/ml) for 2 h at 37 °C andmitochondrial membrane potential was measured using
vs. DA (400 μM); Student's t-test, paired.was measured in a microplate luminometer (Biotek, ELX-800, USA),
keeping appropriate blanks. Caspase 3 activitywas expressed as relative
luminescence units/mg of protein.
The caspase 9 activity was also measured in a similar way using
a commercial kit (Caspase-Glo® 9 Assay kit, Promega, USA) with a
luminogenic caspase-9 substrate (LEHD-aminoluciferin).
2.16. Protein estimation
The protein was estimated after solubilizing the membranes in 1%
SDS by a modiﬁcation of Lowry's method [49].
3. Results
3.1. Alteration of mitochondrial transmembrane potential and
phosphorylation capacity by DA during extended incubation
Results presented in Fig. 1A show a dose-dependent loss of brain
mitochondrial membrane potential as indicated by the decrease in
mitochondrial membrane potential sensitive JC-1 ﬂuorescence fol-
lowing an extended incubation with DA (100–400 μM) for 2 h with
nearly 65% decrease in ﬂuorescence with 400 μM of DA. Further, DA
induced loss of rat brain mitochondrial membrane potential was not
prevented by hydroxyl radical scavengers like mannitol (20 mM) or
DMSO (20 mM) or the antioxidant enzyme catalase (50 μg/ml) or the
metal chelator DTPA (Fig. 1B). On the other hand, thiol compounds
like GSH (2.5 mM) and NAC (2.5 mM) prevented nearly completely
the DA-mediated loss of mitochondrial membrane potential (Fig. 1B).
Mannitol, DMSO, DTPA, catalase, GSH and NAC individually at con-
centrations used in this study did not have any detrimental effect
on mitochondrial membrane potential in the absence of DA (results
not shown).
The phosphorylation capacity of rat brain mitochondria as
measured by inorganic phosphate utilization was dramatically
reduced after incubation for 2 h with DA (100–400 μM) in a dose-
dependent manner. In the presence of 400 μM DA, phosphorylation
capacity of mitochondria after incubation for 2 hwas reduced bymore
than 90% (Fig. 2A). Such DA-mediated loss of mitochondrial phos-
phorylation capacity was not prevented by radical scavengers like
mannitol (20 mM) or benzoate (20 mM) or the antioxidant enzyme
catalase (50 μg/ml) or themetal-chelator DTPA (0.1 mM) as presented
in Fig. 2B. However, GSH (2.5 mM) or NAC (2.5 mM) provided veryochondria were incubated without (control) or (A) with varying concentrations of DA
(2.5 mM) or mannitol (MAN, 20 mM) or DMSO (20 mM) or DTPA (0.1 mM) or catalase
JC-1. Values are the means+SEM of eight observations. *pb0.001 vs. control,Ψpb0.001
Fig. 2. Inhibition of mitochondrial phosphorylation capacity after in vitro incubation with DA. Rat brain mitochondria were incubated without (control) or (A) with varying
concentrations of DA (100–400 μM) or (B) with DA (400 μM) in the presence or absence of GSH (2.5 mM) or NAC (2.5 mM) or catalase (CAT, 50 μg/ml) ormannitol (MAN, 20 mM) or
benzoate (BNZ, 20 mM) or DTPA (0.1 mM) for 2 h at 37 °C and phosphorylation capacity was measured by as inorganic phosphate utilization as detailed in Materials and methods.
The values are the means±SEM of eight observations. *pb0.001 vs. control, Ψpb0.001 vs. DA (400 μM); Student's t-test, paired.
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phosphorylation capacity. Catalase, DTPA, mannitol, benzoate, GSH
or NAC when added individually in the absence of DA did not affect
mitochondrial phosphorylation but DMSO (20 mM) had a distinct
inhibitory effect (results not shown) which prompted us to use
benzoate as a radical scavenger in stead of DMSO for this set of assays.3.2. Effect of DA onmitochondrial membrane potential andmitochondrial
phosphorylation capacity during short-term incubation
When rat brain mitochondria were incubated with DA (400 μM)
for a brief period (up to 15 min), no signiﬁcant decrease in trans-
membrane potential was noticed, while phosphorylation capacity was
diminished marginally (~10%, Fig. 3). However, when tyrosinase
(250 units/ml) was added in the incubation mixture containing brain
mitochondria and DA, a striking loss of mitochondrial transmembrane
potential and phosphorylation capacity was observed within 15 min
and these effects were also prevented nearly completely by GSH
(2.5 mM) present in the incubation mixture (Fig. 3). Tyrosinase alone
showed no detrimental effect on mitochondrial membrane potentialFig. 3. Tyrosinase potentiates DA induced loss of mitochondrial membrane potential and pho
preparations were incubated without (control) or with DA (400 μM) or DA (400 μM) plus t
37 °C followed by themeasurement of mitochondrial membrane potential (A) andmitochon
means±SEM of six observations. Statistical signiﬁcance was calculated by Student's t-test,or on mitochondrial phosphorylation in the absence of DA (data not
shown).3.3. ROS production in PC12 cells following DA exposure
When PC12 cells were exposed to varying concentrations of DA
(100–400 μM), a dose-dependent increase in ROS production was
noticed at 24 h asmeasured by using the ROS-reacting ﬂuorescent dye
DCF-DA (Fig. 4A). The increase in ROS production was also observed,
but to a lesser extent, at 12 h after DA exposure (data not shown).
N-acetylcysteine (2.5 mM) or MAO-A inhibitor clorgyline (10 μM)
prevented DA induced ROS production by nearly 85% and 75%
respectively (Fig. 4A). However, co-incubation with cell-permeable
radical scavenger TEMPOL (1 mM) provided only a marginal protection
against DA induced ROS production (Fig. 4A).
Using the amplex red method for the measurement of H2O2,
similar results were obtained with a signiﬁcant increase in H2O2
production by PC12 cells at 24 h after DA exposure which was very
signiﬁcantly and nearly to the same extent inhibited by co-incubation
either with NAC (2.5 mM) or clorgyline (10 μM) (data not shown).sphorylation capacity during short-term incubation. Aliquots of rat brain mitochondrial
yrosinase (TYR, 250 U/ml) in the presence and absence of GSH (2.5 mM) for 15 min at
drial phosphorylation capacity (B) as described inMaterials andmethods. Values are the
paired, ♦pb0.05 vs. control, *pb0.001 vs. DA, Ψpb0.001 vs. DA+TYR.
Fig. 4. ROS generation and formation of mitochondrial quinoprotein adducts in PC12
cells after DA exposure. PC12 cells were incubated for 24 h without (control) or with
varying concentrations of DA (100–400 μM) or with 400 μMDA in the presence of other
additions like NAC (2.5 mM) or GSH (2.5 mM) or clorgyline (CLOR, 10 μM) or TEMPOL
(TEMP, 1 mM) as described in Materials and methods. Intracellular ROS generation was
measured using H2DCFDA (A) while quinoprotein adduct formation in mitochondrial
fraction was determined spectrophotometrically (B). Each value is expressed as the
mean±SEM of ﬁve observations. ♦pb0.01; *pb0.001 vs. respective controls; Фpb0.05
and Ψpb0.001 vs. DA (400 μM), Student's t-test, paired.
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cells
When PC12 cells were incubated with DA (400 μM) for 24 h in
RPMI medium, oxidation products of DA like quinones and melanin
accumulated in the medium and the process was nearly completely
prevented by quinone scavengers like NAC and GSH (Table 1). Under
similar conditions of incubation DA caused a signiﬁcant increase in
quinoprotein adduct formation in mitochondrial fraction after 24 h
treatment in a dose-dependent manner. N-acetyl cysteine (2.5 mM)Table 1
Accumulation of quinones and melanin in the medium during DA exposure of PC12
cells.
Incubation condition Quinone (A480/ml) Melanin (A405/ml)
Control 0.008±0.001 0.024±0.003
DA 0.247±0.018⁎ 0.350±0.017⁎
DA+NAC 0.033±0.005⁎⁎ 0.013±0.002⁎⁎
DA+GSH 0.031±0.008⁎⁎ 0.057±0.003⁎⁎
PC12 cells were incubated for 24 h without (control) or with DA (400 μM) in the
presence or absence of NAC (2.5 mM) or GSH (2.5 mM). After the incubation quinone
and melanin formation in the medium were measured spectrophotometrically as
described in Materials and methods. Each value is expressed as the mean±SEM of four
observations.
⁎ pb0.001 vs. respective controls.
⁎⁎ pb0.001 vs. DA (400 μM), Student's t-test, paired.almost completely (~85%) prevented DA induced quinoprotein
adduct formation while GSH (2.5 mM) only partially (~40%) pre-
vented the latter process (Fig. 4B). Surprisingly, clorgyline (10 μM)
also prevented the DA mediated mitochondrial quinoprotein adduct
formation in PC12 cells marginally (~15%), but TEMPOL did not show
any effect in this regard (Fig. 4B).
3.5. Effect of DA on mitochondrial bioenergetics in PC12 cells
Following 24 h of DA exposure, a signiﬁcant dose-dependent
(100–400 μM) decrease in the activities of mitochondrial respiratory
chain complexes (complex I, complex II–III and complex IV) was
noticed (Fig. 5A, B and C). The extent of inhibition of complex I (67%)Fig. 5. Inhibition of mitochondrial respiratory chain complexes in PC12 cells following
DA exposure. PC12 cells were incubated alone (control) or with varying concentrations
of DA (100–400 μM) or with 400 μM DA in the presence of NAC (2.5 mM) or clorgyline
(CLOR, 10 μM) for 24 h as described in the text. Mitochondria were isolated from the
cells and activities of complex I (A), complex II–III (B) and complex IV (C) measured as
described inMaterials andmethods. The values are themeans±SEMof six observations.
Statistical signiﬁcance was calculated by Student's t-test, paired. ♦pb0.05, **pb0.01;
*pb0.001 vs. respective controls; λpb0.05; Фpb0.01; Ψpb0.001 vs. DA (400 μM).
669S. Jana et al. / Biochimica et Biophysica Acta 1812 (2011) 663–673and complex IV (65%) by DA (400 μM) was found to be reasonably
similar while complex II–III was much less affected by DA treatment
(Fig. 5). The extent of DA (400 μM) effect on mitochondrial ETC
complexes was also time-dependent up to 24 h (data not shown). The
thiol antioxidant NAC (2.5 mM) provided a very signiﬁcant protection
against DA induced inhibition of mitochondrial respiratory complexes
blocking the DA effects on complex I, complex II–III and complex IV
by approximately 80%, 75% and 85% respectively (Fig. 5). However,
MAO-A inhibitor clorgyline (10 μM) was only partially effective in
preventing the effects of DA on respiratory complexes in PC12 cells
(Fig. 5).
Following 24 h of exposure to DA (100–400 μM) a signiﬁcant dose-
dependent decrease in mitochondrial transmembrane potential was
also observed in PC12 cells as indicated by the decrease in the ratio of
JC-1 emission ﬂuorescence at 590 and at 527 nm (Fig. 6A). N-acetyl
cysteine provided a very signiﬁcant protection (90%) against DA
induced mitochondrial membrane depolarization but clorgyline was
only partially effective (~26%) in this respect (Fig. 6A). When added
in the absence of DA in the culture media with PC12 cells, NAC or
clorgyline did not show any noticeable effect on mitochondrial
complex activities and mitochondrial transmembrane potential after
24 h of incubation (results not shown). The impairment of mitochon-
drial oxidative phosphorylation process following 12 or 24 h exposure
was also evident from a decreased basal ATP content in PC12 cells
(Fig. 6B).
3.6. Effect of DA exposure on PC12 cell viability: Apoptosis and caspase
activation
The exposure of PC12 cells to DA (100–400 μM) for 24 h led to a
signiﬁcant loss of cell viability in a dose-dependent manner (Fig. 7A).
Cell death occurred to the extent of nearly 40% after 24 h exposure to
400 μM of DA (Fig. 7A). Concurrent incubation with thiol-antioxidant
NAC (2.5 mM) or MAO-A inhibitor clorgyline (10 μM) resulted in
nearly 80% and 28% protection respectively against DA induced
cell death (Fig. 7B). N-acetyl cysteine or clorgyline when added in
the absence of DA in the culture media with PC12 cells for 24 h did
not show detrimental effect on the viability of PC12 cells (results
not shown).
Following DA (400 μM) treatment for 24 h, typical apoptotic
nuclear morphology e.g. condensed and fragmented nuclei with
several discrete chromatin bodies, appeared in PC12 cells with respectFig. 6.Mitochondrial dysfunction in intact PC12 cells after DA exposure. (A) PC12 cells were
400 μM DA in the presence of NAC ( 2.5 mM) or clorgyline (CLOR, 10 μM) for 24 h as detail
PC12 cells wasmeasured by using JC-1. Each value represents themean±SEM of six observat
or with DA (400 μM) for varying periods of time (6–24 h) as described in Materials and
observations. **pb0.01, *pb0.001 vs. respective controls: Фpb0.05, and Ψpb0.001 vs. contto the untreated control cells (Fig. 8A and B). The activities of caspase
3 and caspase 9 were also evaluated in DA-treated PC12 cells to
further substantiate the involvement of apoptosis in cell death.
A dose-dependent increase in caspase 3 and caspase 9 activities
was noticed in PC12 cells after 24 h of DA exposure (Fig. 9A and B).
The caspase-3 activity was increased by ~3.4 folds and caspase-9
activity by ~2.8 folds at 24 h after DA (400 μM) treatment. Concurrent
presence of NAC (2.5 mM) in the medium markedly prevented DA
induced activation of caspase 3 and caspase 9, while clorgyline
(10 μM) was only partially effective in this respect (Fig. 9A and B).
4. Discussion
4.1. DA impairs oxidative phosphorylation in isolated rat brain
mitochondria
The effects of DA on isolated mitochondria have been widely
reported indicating alterations in mitochondrial respiration, activities
of ETC complexes, mitochondrial membrane potential and activation
state of permeability transition pore [16,18,45,50–52]. Most studies
have used a short-term exposure of mitochondria to DA (5–15 min)
followed by themeasurement of mitochondrial functional parameters
but the results have been somewhat inconsistent. A signiﬁcant
inhibition of mitochondrial state III respiration by DA (100 μM) has
been reported by several groups while others have failed to observe
such a change at 70 μMDA concentration [16,18,53]. Calcium induced
mitochondrial membrane swelling indicative of opening of perme-
ability transition pore has been variously reported to be increased,
decreased or unaltered by DA from various groups under comparable
incubation conditions [16,45,51,53]. Likewise, DAhas been reported to
produce a substantial loss of mitochondrial membrane potential or to
have no effect during short-term incubation [45,51,53]. Further, the
effects of DA on mitochondrial respiratory chain activity after short-
term exposure as measured by direct enzyme assays in lysed
mitochondrial preparation have been equivocal in several different
studies [50,52–54]. Apart from such inconsistencies, a short-term
exposure is clearly unsuitable for identiﬁcation of the toxic actions of
quinones onmitochondria, since quinone formation fromDAduring in
vitro incubation is very slow. Our earlier study, however, has clearly
demonstrated that during extended incubation (2 h) DA produces a
very signiﬁcant inhibition of mitochondrial ETC complexes in a dose-
dependent manner which is mediated by toxic quinones instead oftreated without (control) or with DA in varying concentrations (100–400 μM) or with
ed in Materials and methods and the mitochondrial transmembrane potential in intact
ions. (B) Intracellular ATP content wasmeasured in PC12 cells treated without (control)
methods. Values (expressed as percentage of control) are the means±SEM of four
rol+DA (400 μM). Student's t-test, paired.
Fig. 7. Effect of DA on cell viability. PC12 cells were treated with DA (400 μM) for varying periods of time (6–24 h) (A) or with varying concentrations (100–400 μM) of DA and with
400 μM DA in the presence of NAC ( 2.5 mM) or clorgyline (CLOR, 10 μM) for 24 h (B) as mentioned in the text. At the end of the incubation, the degree of cell death was assessed
by trypan blue dye exclusion method. Each value is expressed as the mean±SEM of ten observations. ♦pb0.05, *pb0.01 vs. control:Фpb0.05,Ψpb0.01, vs. DA (400 μM), Student's
t-test, paired.
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mitochondrial membrane depolarization and loss of phosphorylation
capacity during extended in vitro incubation in a dose-dependent
manner which are not prevented by radical-scavengers, catalase or
metal-chelators indicating that ROS are not involved in this process
(Figs. 1 and 2). On the other hand, GSH and NAC prevent DA effects
nearly completely presumably through their quinone scavenging
functions (Figs. 1 and 2). The involvement of toxic quinones in DA
induced mitochondrial membrane depolarization and inhibition of
phosphorylation capacity has been conﬁrmed from our short-term
experiments with tyrosinase which rapidly converts DA to quinone
products without producing ROS. Tyrosinase causes a dramatic
potentiation of DA effects on mitochondria during 15 min exposure
(Fig. 3). The present results are, therefore, in complete agreementwith
our earlier published data where quinone-dependent inhibition of
brain mitochondrial ETC activity is demonstrated during extended
incubation [19,55]. It is likely that DA induced ETC inhibition is the
primary event that leads to loss of mitochondrial membrane potential
with consequent loss of mitochondrial phosphorylation presumably
through uncoupling phenomenon. It may be interesting to point out
here that the degree of inhibition of phosphorylation is much greater
than the loss of mitochondrial membrane potential at each concen-
tration of DA (Figs. 1 and 2). This indicates that the loss of mi-
tochondrial transmembrane potential only partly accounts for the
inhibition of phosphorylation capacity which in addition may be
further affected by other mechanisms including DA-mediated damage
to complex V and phosphate transport system. Other studies have alsoFig. 8. Induction of apoptosis in cultured PC12 cells by DA. PC12 cells were treated without (A
described in Materials and methods. The ﬁgures are representatives of a set of identical expe
indicated by arrowheads.revealed the toxic actions of DA derived quinones on mitochondrial
permeability transition and state IV respiration and swelling and
disruption of outer and inner mitochondrial membranes with
associated collapse of mitochondrial membrane potential [16,56].
The effects of DA-derived quinones on mitochondrial proteins
have been extensively analyzed in recent publications using 2D-
electrophoresis, image analysis, autoradiographic determination or
mass spectrometric analysis revealing a series of proteins involved in
mitochondrial structure maintenance, transport and oxidative phos-
phorylationwhich are damaged by quinones and such results strongly
support our present ﬁndings [35,36]. It has been further shown that
tetrahydrobiopterin facilitates the formationof quinoneproducts from
DA which in turn lead to dopaminergic neuronal damage through
inhibition of mitochondrial ETC activity, membrane depolarization
and the release of cytochrome c [57]. Another recent study has
highlighted the toxic effects of DA derived quinone products on
isolated respiring mitochondria through interaction with NADH and
GSH pool [58].
4.2. DA causes mitochondrial dysfunctions in PC12 cells: role of ROS and
toxic quinones
Several studies have demonstrated that DA added to the medium
causes apoptotic death of PC12 cells or other cell lines or primary
culture of neurons, but the importance of mitochondrial bio-
energetic failure in this context has not been clearly worked out
[13,20,26,59,60]. The results of DA effects on isolated brain) or with DA (400 μM) for 24 h (B) followed by nuclear staining with Hoechst 33258 as
riments repeated four times. Condensed and fragmented nuclei typical of apoptosis are
Fig. 9. Caspase activation in cultured PC12 cells by DA. PC12 cells were treated without
(control) or with DA (400 μM) for varying periods of time (6–24 h) or with 400 μM DA
in the presence of NAC (2.5 mM) or clorgyline (CLOR, 10 μM) for 24 h. Caspase 3 (A)
and caspase 9 (B) activities were measured by luminometric method as explained in
Materials andmethods. Each value is expressed as themean±SEM of ﬁve observations.
♦pb0.05, *pb0.001 vs. control; Фpb0.01, Ψpb0.001 vs. DA (400 μM), Student's t-test,
paired.
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dent mitochondrial impairment is also operative when intact PC12
cells are exposed to varying concentrations of DA for 24 h and to
further explore the consequences of such DA exposure on cell viability
and apoptosis. When added to the culture medium, DA undergoes
both extracellular and intracellular oxidation to produce ROS and
toxic quinones. The extracellular oxidation is essentially autoxidation,
while both autoxidation and enzymatic oxidation take place in the
intracellular compartment.Within PC12 cells DA can be acted upon by
MAO to produce DOPAC (3,4-dihydroxyphenylacetic acid) and H2O2,
while autoxidation leads to the formation of reactive quinones and
superoxide radicals which can further give rise to H2O2 and other active
oxygen species. Moreover, within the intracellular compartment
DA can be oxidized by the actions of various enzymes like tyrosinase,
prostaglandin H synthase, lipoxygenase and some uncharacterized
enzyme activities to produce toxic quinones [55,61–63].
In the present study the increased ROS production in PC12 cells
after DA exposure is signiﬁcantly prevented by MAO-A inhibitor
clorgyline (Fig. 4A) indicating clearly that H2O2 formation through
MAO-catalyzed oxidation of DA is the predominant mechanism of
ROS production within PC12 cells under this condition. This is furtherveriﬁed by amplex red assay which speciﬁcally measures H2O2 con-
centrations and DA exposed cells have been seen to produce more
H2O2 in our study (data not shown). In this study, we have used only
clorgyline instead of other MAO inhibitors, since MAO-A is predom-
inantly expressed in PC12 cells [64]. The cell-permeable nitroxide
spin-trapping antioxidant TEMPOL is known to scavenge several
species of reactive radicals especially superoxide radicals and also
hydroxyl and carbon-centered radicals and it can also inhibit Fenton's
reaction [65–68]. In our experimental system it provides only mild
protection against H2O2 accumulation in PC12 cells after DA exposure
presumably because TEMPOL does not remove H2O2 directly and
can in fact generate H2O2 while scavenging superoxide radicals by
dismutation reaction [65,69]. Apart from ROS formation within
PC12 cells after DA exposure for 24 h, a considerable increase in
quinoprotein adducts in the mitochondrial fraction of the former
suggests that toxic quinones could be of critical importance in DA
toxicity. N-acetyl cysteine is a potent scavenger of both ROS and toxic
quinones [70] and expectedly prevents both the increased intracel-
lular accumulation of ROS and formation of quinoprotein adducts in
mitochondria in DA exposed PC12 cells (Fig. 4). It has been shown
earlier that clorgyline independent of its inhibitory action on MAO-A
can inactivate some uncharacterized mitochondrial enzyme convert-
ing DA to quinone products and thus can decrease the formation of
quinoprotein adducts in mitochondria co-incubated with DA [19,55].
This mechanism probably explains our present observation that
even clorgyline partially prevents quinoprotein adduct formation in
mitochondrial fraction of DA exposed PC12 cells. The actions of
clorgyline and NAC have provided us with important clues to reveal
the contributions of ROS and toxic quinones to the damaging effects of
DA on mitochondria within intact PC12 cells. In DA exposed PC12
cells, there occurs a marked failure of mitochondrial functions with
loss of transmembrane potential, and inhibition of ETC complexes
at various levels (Figs. 5 and 6). The alterations in mitochondrial
functions after DA exposure is only slightly protected by clorgyline
which, however, prevents the increased formation of intracellular ROS
from DA very considerably and thus this observation rules out any
signiﬁcant involvement of ROS in mediating DA effects on mitochon-
dria of intact PC12 cells. N-acetyl cysteine on the other hand nearly
completely protects mitochondria of PC12 cells from the deleterious
actions of DA, which can be ascribed to its quinone scavenging actions
and ability to prevent quinoprotein adduct formation. The fact that
clorgyline also partially prevents the formation of quinoprotein
adducts (Fig. 4B) probably explains the ability of the former to confer
some protection against DA inducedmitochondrial inactivation under
our experimental conditions. The involvement of toxic quinones in
DA mediated mitochondrial impairment in intact PC12 cells is in clear
agreement with our results obtained with isolated rat brain mito-
chondria in the present study as also those in earlier studies [19,55]. In
contrast to our present results, direct uptake of DA in mitochondria
followed by inhibition of complex I without any involvement of
oxidative catabolites of DA in intact SHSY5Y cells has also been
reported [52]. Likewise ROS mediated damage to mitochondria after
exposure of cells to DOPA or DA has also been reported [17,42].
However, the present study has clearly brought out the role of toxic
quinones in triggering mitochondrial damage in intact PC12 cells
and this is well supported by some proteomic based recent studies
which have identiﬁed several mitochondrial proteins modiﬁed by DA
derived quinones in SHSY5Y cells or rat brain mitochondria [35,36].
The contributions of extracellularly generated quinones and those
produced intracellularly from DA have also been compared in this
study in the context of DA cytotoxicity by observing the effects of
potent quinone scavengers like the cell-permeable NAC and the cell-
impermeable GSH on generation of quinones and melanin in the
medium and quinoprotein adduct formation in the mitochondrial
fraction of the cells (Table 1). Our results clearly demonstrate that
quinone products including melanin accumulate after DA addition in
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by both GSH and NAC (Table 1). On the other hand, the formation of
quinoprotein adducts in the mitochondrial fraction of PC12 cells upon
DA exposure is markedly prevented by NAC but only partially by GSH
(Table 1). Thus quinoprotein adduct formation in mitochondria
and concomitant impairment of mitochondrial functions may result
partly from the entry of reactive quinones from the external medium
but also substantially may be caused by intracellularly generated
quinones after DA is taken up by the cells. Earlier studies using DA
transporter blocker nomifensine have also suggested the important
role of intracellular oxidation of DA in its cytotoxicity [27,28].
4.3. DA induces cell death and apoptosis in PC12 cells through quinone
oxidation products
Since mitochondrial impairment has been linked with several
damage pathways like apoptosis, necrosis and autophagy [31], we
have investigated the effects of DA exposure on the viability of PC12
cells. In our study, a signiﬁcant and progressive loss of cell viability
has been observed after DA exposure with activation of caspase 3 and
caspase 9 and nuclear morphology characteristic of apoptosis as
observed after Hoechst staining (Figs. 7, 8 and 9). The loss of cell
viability and activation of caspases followingDA exposure are partially
protected by clorgyline but very conspicuously by NAC (Figs. 7 and 9).
The effects of clorgyline and NAC on DA induced cell death are thus
remarkably similar to their protective actions against mitochondrial
impairment caused by DA. It appears that quinone mediated
mitochondrial damage after DA exposure acts as a trigger to initiate
cell death by apoptosis in PC12 cells and NAC provides a dramatic
protective effect through its quinone-scavenging property. Several
earlier studies have shown DA or L-DOPA induced death of various
catecholaminergic cells where DA derived ROS have been implicated
in the damage process [20,42,59,60]. However, in such studies thiol
antioxidant NAC or GSH has been shown consistently to produce
signiﬁcant protective actionwhile various antioxidants have produced
variable results [20,26,59,60,71,72]. It is therefore conceivable that the
protective action of NAC against DA cytotoxicity is unrelated to its
antioxidant property andmay be explained by its quinone scavenging
property as shown here as also in our earlier published study [70]. The
importance of toxic quinones in DA cytotoxicity is further supported
by earlier studies where human SK–N–MC neuroblastoma cells stably
transfected with NAD(P)H quinone oxidoreductase 1 (NQO1) have
shown to be highly protective against DA mediated cell death [73].
Although mitochondrial dysfunction has been highlighted as the
primary cause for DA induced cell death in this study, the involvement
of parallel damage pathways by toxic quinones cannot be ruled out. In
particular, after DA exposure, the activation of NF-κB, or multiple MAP
kinase pathways or proteasomal dysfunction or the over expression of
α-synuclein could be important in the context of cell death [24–27,74].
Since mitochondrial dysfunction in our experimental model has led
to ATP depletion, it seems a little paradoxical that apoptotic caspase
activation has occurred in such energetically compromised PC12 cells.
From the data presented in Figs. 6B and 9, it appears that apoptotic
caspase activation in PC12 cells starts within 6 h of DA exposure when
the basal ATP concentration in PC12 cells is still maintained.
Dopamine induced cytotoxicity has been suggested to involve
apoptosis, necrosis and autophagy in different experimental models
and in all three forms of cellular death mitochondrial dysfunction
plays a central role [31]. The present study showing the various forms
of mitochondrial dysfunction both in isolated mitochondria and in
intact PC12 cells through DA derived quinone products is, therefore,
extremely signiﬁcant. However, the cross-talk among the damage
pathways and mitochondrial dysfunction needs to be investigated
thoroughly and it is further important to compare these results from
experimental model systems with post mortem data so as to get a
clear view of the in vivo pathology of the disease. More importantlyfrom the point of view of drug development it is important to identify
the initial toxic species triggering these interdependent damage
pathways within dopaminergic neurons. The importance of toxic
quinones in DA cytotoxicity as has been highlighted here implies that
scavengers of quinones rather than antioxidants could be potential
neuroprotective agents in PD and compounds like NAC can serve as
parent molecules fromwhich more potent neuroprotective molecules
can be developed in PD.
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